跳至主要内容
临床试验/NCT00532363
NCT00532363已完成不适用

Obesity-related Pseudo-asthma (ORPA): Description of a Novel Clinical Entity

Laval University1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2005年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
1

研究概览

简要总结

Clinicians frequently observed that obese women referred for severe asthma do not respond to treatment. These patients, despite the presence of wheezing, often have normal expiratory flows and normal or "borderline" airway responsiveness.

It is therefore possible that this mode of presentation reflect a pseudo-asthmatic state for which clinical definition and characteristics and optimal management remain to be determined.

The aim of this study was to study the pulmonary physiological and airway inflammatory characteristics and response to treatment of obese women considered to have clinically severe asthma in order to demonstrate that some of these patients have a phenotype that is not that of asthma.

详细描述

Twenty-five obese women (BMI over 30) and 25 non-obese women (18>BMI<25) considered to have severe asthma by their physician and requiring corticosteroids to control their asthma will have the following investigation:

  • Respiratory questionnaires focussing on the nature and time-course of symptoms, asthma control criteria, medication use.
  • Physical examination, including measures of BMI, waist, hips and ratio waist/hips
  • Blood test for Complete Blood Count, blood glucose, total IgE levels and markers of systemic inflammation (C-Reactive Protein, fibrinogen...)
  • Spirometry and bronchodilator response.
  • Induced sputum analysis and Exhaled Breath Condensate pH to assess airway inflammation.
  • Skin prick tests with a battery of common airborne allergens
  • Measurement of lung volumes and airway resistance + MIP and MEP.
  • Methacholine challenge (up to 16 mg/ml) with Borg scores for breathlessness and chest tightness.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Will be women aged 18 years and over
  • Will be in good health apart from asthma or obesity as determined by history and physical examination (No other condition that could influence the proposed tests).
  • All will be non smokers or ex-smokers for more than six months with a smoking history of no more than 10 pack- years (i.e., one pack per day or its equivalent for 10 years.)
  • Subjects will have a physician's made diagnosis of severe asthma and treated with corticosteroids.

排除标准

  • Subjects who are, in the opinion of the investigator, mentally or legally incapacitated thus preventing informed consent from being obtained.
  • Subjects having a co-existing illness that precludes them from the trial.
  • Pregnancy or lactation
  • Contraindication to the prednisone treatment.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Louis-Philippe Boulet

MD, FRCPC, FCCP

Laval University

研究点 (1)

Loading locations...

相似试验